![]() ![]() ![]() ![]() |
Name: | tnaCAB | ||||||||||
Synonym(s): | OP00116, tna, tnaAB | ||||||||||
Gene(s): | tnaC, tnaA, tnaB Genome Browser M3D Gene expression COLOMBOS | ||||||||||
Note(s): | The tnaCAB operon codes for two key enzymes in tryptophan metabolism, including tryptophanase. It is regulated by attenuation within its leader region in response to tryptophan abundance. When tryptophan is present, transcription continues through a Rho-dependent terminator and tnaA and tnaB are transcribed Stewart V,1985. In addition, tnaCAB is also subject to regulation at the level of transcriptional initiation via CRP, although this is not the main regulatory control on the operon Stewart V,1985. Attenuation of tnaCAB occurs via ribosomal pausing at the tail end of the tnaC leader sequence. As translation of the leader peptide nears completion, it halts with the terminal proline of TnaC still attached to its tRNA and stuck within the ribosome. In the absence of tryptophan, peptide chain release factor RF1 and peptide chain release factor RF2 cleave TnaC from the tRNA and free the ribosome. This, in turn, allows access by Rho to a Rho-dependent terminator that then prematurely terminates transcription of tnaCAB. In the presence of tryptophan, release by RF1 and RF2 is prevented, and the ribosome remains in place, blocking access by Rho to the terminator and allowing continued transcription of the operon Stewart V,1985. Yanofsky C,1996. Konan KV, Yanofsky C,2000. Gong F, Yanofsky C,2001. Gong F, Ito K, Nakamura Y, Yanofsky C,2001. Gong F, Yanofsky C,2002. Eventually, the stalled ribosome is cleared away by ribosome recycling factor and peptide chain release factor RF3 Gong M,2007. As a natural consequence of this mechanism, attenuation at tnaCAB depends on both translation of the leader peptide and the presence of Rho Yanofsky C, Horn V,1995. Gish K, Yanofsky C,1995. Gollnick P,1990. This close coupling of transcription and translation is achieved via an RNA polymerase-pausing mechanism. There is a pause site toward the latter end of the tnaC sequence. The RNA polymerase pauses there, allowing time for the ribosome to attach to the nascent RNA and begin translation. When the ribosome reaches the paused RNA polymerase, transcription continues. This pausing mechanism ensures that the ribosome is in the proper position to regulate the Rho-dependent terminator in response to tryptophan abundance Gong F, Yanofsky C,2003. Rho-dependent termination within the tnaC sequence depends on both a rut- and a boxA-like sequence within the leader region of the operon Konan KV, Yanofsky C,2000. The role of the boxA-like sequence in promoting termination is peculiar, as the actual boxA sequence normally acts as an antiterminator Gong F, Yanofsky C,2002. Stalling of the ribosome during translation of TnaC depends on a complex interaction between the leader peptide and the ribosome. Attenuation is completely dependent on the sole tryptophan within the leader peptide sequence. Mutations at this position make tryptophan induction of tnaCAB impossible Gollnick P,1990. Specific residues within TnaC, most notably Asp-16 and Pro-24, are essential for inhibiting clearing of the TnaC-tRNA complex from the peptidyl transferase center within the ribosome and for altering the conformation of the 23S RNA in a manner that may help generate a tryptophan-binding site on the ribosome Cruz-Vera LR, Yanofsky C,2008. Both YdgT and HolE appear to influence expression of tnaA by enhancing transcription termination at the leader DNA sequence Dietrich M, Pedró L, García J, Pons M, Hüttener M, Paytubi S, Madrid C, Juárez A,2014. Based on work with mutant strains, it was determined that FNR, NarL, and NarP negatively regulate the tnaCAB operon in the exponential growth phase during anaerobic respiration of nitrate Lai Y, Xu Z, Yan A,2017 ZraR represses tnaAB operon transcription. This operon is among the most strongly regulated, and its genes are repressed by ZraR with a 20-fold and a 50-fold drop in expression, respectively, compared to the wild type or a zraR strain, reducing the amount of indole by downregulating the tnaAB operon Rome K,2018 The tnaA gene is upregulated by the antibiotic... |
||||||||||
Evidence: | [COMP-HINF] Inferred by a human based on computational evidence [EXP-IEP-COREGULATION] Inferred through co-regulation |
||||||||||
Reference(s): |
[1] Deeley MC., et al., 1981 [2] Deeley MC., et al., 1982 [3] Edwards RM., et al., 1982 [4] Gish K., et al., 1993 [5] Stewart V., et al., 1985 |
||||||||||
Promoter | |||||||||||
Name: | tnaCp | ||||||||||
+1: | 3888411 | ||||||||||
Sigma Factor: | Sigma70 Sigmulon | ||||||||||
Distance from start of the gene: | 24 | ||||||||||
Sequence: |
cgattcacatttaaacaatttcagaatagacaaaaactctgagtgtaataatgtagcctcGtgtcttgcgaggataagtgc -35 -10 +1 |
||||||||||
Evidence: |
[COMP-AINF] [EXP-IDA-TRANSCRIPTION-INIT-MAPPING] [RS-EPT-CBR] |
||||||||||
Reference(s): |
[2] Deeley MC., et al., 1982 [6] Huerta AM., et al., 2003 [7] Salgado H, et al., 2012 |
||||||||||
Terminator(s) | |||||||||||
Type: | rho-dependent | ||||||||||
Sequence: | atgtgtgaccTCAAAATGGTTCAATATTGACAACAAAATTGTCGATCACCGCCCTTGAtttgcccttc | ||||||||||
Reference(s): | [8] Konan KV., et al., 1997 |
Type | Transcription factor | Function | Promoter | Binding Sites | Growth Conditions | Evidence | Confidence level (C: Confirmed, S: Strong, W: Weak) | Reference(s) | |||
---|---|---|---|---|---|---|---|---|---|---|---|
LeftPos | RightPos | Central Rel-Pos | Sequence | ||||||||
proximal | CRP-cyclic-AMP | activator | tnaCp | 3888341 | 3888362 | -59.5 | ctccccgaacGATTGTGATTCGATTCACATTTaaacaatttc | nd | [EXP-IEP-GENE-EXPRESSION-ANALYSIS], [COMP-AINF-SIMILAR-TO-CONSENSUS], [COMP-HINF-SIMILAR-TO-CONSENSUS], [EXP-IDA-BINDING-OF-CELLULAR-EXTRACTS] | S | [5], [10] |
Type | Transcription factor | Function | Promoter | Binding Sites | Growth Conditions | Evidence | Confidence level (C: Confirmed, S: Strong, W: Weak) | Reference(s) | |||
---|---|---|---|---|---|---|---|---|---|---|---|
LeftPos | RightPos | Central Rel-Pos | Sequence | ||||||||
remote | TorR-phosphorylated | activator | tnaCp | 3888304 | 3888313 | -102.5 | cgtaatttatAATCTTTAAAaaaagcattt | nd | [EXP-IEP-GENE-EXPRESSION-ANALYSIS], [EXP-IDA-BINDING-OF-PURIFIED-PROTEINS] | W | [9] |
proximal | TorR-phosphorylated | activator | tnaCp | 3888351 | 3888360 | -55.5 | gattgtgattCGATTCACATttaaacaatt | nd | [EXP-IEP-GENE-EXPRESSION-ANALYSIS], [EXP-IDA-BINDING-OF-PURIFIED-PROTEINS] | W | [9] |
Name: | tnaC | ||||||||||
Gene(s): | tnaC Genome Browser M3D Gene expression COLOMBOS | ||||||||||
Evidence: | [EXP-IDA-BOUNDARIES-DEFINED] Boundaries of transcription experimentally identified | ||||||||||
Reference(s): |
[2] Deeley MC., et al., 1982 [8] Konan KV., et al., 1997 |
||||||||||
Promoter | |||||||||||
Name: | tnaCp | ||||||||||
+1: | 3888411 | ||||||||||
Sigma Factor: | Sigma70 Sigmulon | ||||||||||
Distance from start of the gene: | 24 | ||||||||||
Sequence: |
cgattcacatttaaacaatttcagaatagacaaaaactctgagtgtaataatgtagcctcGtgtcttgcgaggataagtgc -35 -10 +1 |
||||||||||
Evidence: |
[COMP-AINF] [EXP-IDA-TRANSCRIPTION-INIT-MAPPING] [RS-EPT-CBR] |
||||||||||
Reference(s): |
[2] Deeley MC., et al., 1982 [6] Huerta AM., et al., 2003 [7] Salgado H, et al., 2012 |
||||||||||
Terminator(s) | |||||||||||
Type: | rho-dependent | ||||||||||
Sequence: | atgtgtgaccTCAAAATGGTTCAATATTGACAACAAAATTGTCGATCACCGCCCTTGAtttgcccttc | ||||||||||
Reference(s): | [8] Konan KV., et al., 1997 |
Type | Transcription factor | Function | Promoter | Binding Sites | Growth Conditions | Evidence | Confidence level (C: Confirmed, S: Strong, W: Weak) | Reference(s) | |||
---|---|---|---|---|---|---|---|---|---|---|---|
LeftPos | RightPos | Central Rel-Pos | Sequence | ||||||||
proximal | CRP-cyclic-AMP | activator | tnaCp | 3888341 | 3888362 | -59.5 | ctccccgaacGATTGTGATTCGATTCACATTTaaacaatttc | nd | [EXP-IEP-GENE-EXPRESSION-ANALYSIS], [COMP-AINF-SIMILAR-TO-CONSENSUS], [COMP-HINF-SIMILAR-TO-CONSENSUS], [EXP-IDA-BINDING-OF-CELLULAR-EXTRACTS] | S | [5], [10] |
Type | Transcription factor | Function | Promoter | Binding Sites | Growth Conditions | Evidence | Confidence level (C: Confirmed, S: Strong, W: Weak) | Reference(s) | |||
---|---|---|---|---|---|---|---|---|---|---|---|
LeftPos | RightPos | Central Rel-Pos | Sequence | ||||||||
remote | TorR-phosphorylated | activator | tnaCp | 3888304 | 3888313 | -102.5 | cgtaatttatAATCTTTAAAaaaagcattt | nd | [EXP-IEP-GENE-EXPRESSION-ANALYSIS], [EXP-IDA-BINDING-OF-PURIFIED-PROTEINS] | W | [9] |
proximal | TorR-phosphorylated | activator | tnaCp | 3888351 | 3888360 | -55.5 | gattgtgattCGATTCACATttaaacaatt | nd | [EXP-IEP-GENE-EXPRESSION-ANALYSIS], [EXP-IDA-BINDING-OF-PURIFIED-PROTEINS] | W | [9] |
Name: | tnaAB |
Gene(s): | tnaA, tnaB Genome Browser M3D Gene expression COLOMBOS |
Evidence: | [EXP-IEP-COREGULATION] Inferred through co-regulation |
Reference(s): | [11] Rome K., et al., 2018 |
RNA cis-regulatory element | ![]() |
---|
Regulation, transcriptional elongation | |
Attenuator type: | Translational |
Strand: | forward |
Structure type | Energy | LeftPos | RightPos | Sequence (RNA-strand) | |
---|---|---|---|---|---|
terminator | -13.7 | 3888398 | 3888436 | ctgagtgtaaTAATGTAGCCTCGTGTCTTGCGAGGATAAGTGCATTATgaatatctta |
Notes: "The provided "Sequence" is that of the RNA strand, i.e. U's are shown instead of T's and regulators on the reverse strand will appear as the reverse complement of the sequence delimited by LeftPos-RigtPos" |
Reference(s) |
![]() |
---|---|